Yanfeng Group: Net profit growth of 18.7% Huangyuan gum - high-end amino acid profit growth

March 18, 2014, Yanfeng Group Co., Ltdannounced its full-year results for 2013, with the Group's revenue of RMB11,367 million in 2013, up 2.3% YoY, mainly due to the increase in MSG sales and the increase in sales of yellow raw gums and high-end amino acids, and the cost of raw materials including corn pellets, coal and chemical products decreased compared with 2012Gross margin increased by about 28.2% to RMB2,099 million, while gross margin increased by 3.8 percentage points over the same periodMainly due to the huangyuan rubber business gross margin increased by 11.7 percentage points to 58.3 percent over the same period, in addition to high-end amino acid profit margin is higherNet profit of shareholders increased by about 18.7% to RMB506 million8mr
In terms of high-grade amino acids, in 2013, xinjiang base of high-grade anine base business began to show strong growth, proline, leucine, ialygine, glutamine and other aine-based products for the full year sales of about 2,406 tons (capacity of 3000 tons, up 1 times year-on-year), to achieve sales revenue of about 211 million yuan, up 1.46 times year-on-yearThrough strategic cooperation with Shenhua Pharmaceuticals, the Group's products have been sold to domestic and foreign health care products and pharmaceutical industry8mr
In addition to high-grade amino acids, the Group continued to develop the business of susine and lysine, with sales of 36,600 tons and 5,700 tons, respectively, about 1 times higher than the year-on-year growth, while lysine was a new productSales revenue of both products was RMB350 million, up 90% YoY, of which Susine sales revenue was RMB327 million, up 78% YoY8mr
The Group's short-term goal is to expand the production capacity of Huangyuan and high-grade amino acids in the Xinjiang plant, with a production capacity of 30,000 tons and 4000 tons by the end of 2013In addition, the Group will continue to push for high-profitability new products such as hyaluronic acid, and expect to place new production lines of hyaluronic acid in the Xinjiang plant, with a planned production capacity of 50 tons in 2014 8mr on March 18, 2014, Yanfeng Group Co., Ltd announced its full-year results for 2013, with the Group's revenue of RMB11,367 million in 2013, up 2.3% YoY, mainly due to higher sales of MSG and sales of yellow raw gels and high-end amino acids, and the cost of raw materials including corn pellets, coal and chemical products decreased compared with 2012 Gross margin increased by about 28.2% to RMB2,099 million, while gross margin increased by 3.8 percentage points over the same period Mainly due to the huangyuan rubber business gross margin increased by 11.7 percentage points to 58.3 percent over the same period, in addition to high-end amino acid profit margin is higher Net profit of shareholders increased by about 18.7% to RMB506 million 8mr
　　In terms of high-grade amino acids, in 2013, xinjiang base of high-grade anine base business began to show strong growth, proline, leucine, ialygine, glutamine and other aine-based products for the full year sales of about 2,406 tons (capacity of 3000 tons, up 1 times year-on-year), to achieve sales revenue of about 211 million yuan, up 1.46 times year-on-year Through strategic cooperation with Shenhua Pharmaceuticals, the Group's products have been sold to domestic and foreign health care products and pharmaceutical industry 8mr
　　In addition to high-grade amino acids, the Group continued to develop the business of susine and lysine, with sales of 36,600 tons and 5,700 tons, respectively, about 1 times higher than the year-on-year growth, while lysine was a new product Sales revenue of both products was RMB350 million, up 90% YoY, of which Susine sales revenue was RMB327 million, up 78% YoY 8mr
　　The Group's short-term goal is to expand the production capacity of Huangyuan and high-grade amino acids in the Xinjiang plant, with a production capacity of 30,000 tons and 4000 tons by the end of 2013 In addition, the Group will continue to push for high-profitability new products such as hyaluronic acid, and expect to place new production lines of hyaluronic acid in the Xinjiang plant, with a planned production capacity of 50 tons in 2014 8mr
Share it on feed